felid
felin
leukemia
viru
felv
infect
result
varieti
outcom
rang
abort
viru
readili
elimin
never
detect
progress
infect
persist
viremia
viral
shed
recent
novel
outcom
postul
low
felv
infecti
dose
cat
expos
faec
persist
infect
cat
seroconvert
indic
infect
remain
neg
proviru
antigen
blood
felv
proviru
found
tissu
bone
marrow
infect
usual
consid
necessari
stage
diseas
progress
investig
impact
low
felv
dose
young
cat
test
hypothesi
low
dose
exposur
may
lead
unknown
pathogenesi
infect
without
involv
bone
marrow
cat
infect
oronas
variabl
viral
dose
blood
provir
viral
load
follow
week
postinfect
tissu
provir
load
determin
well
immun
respons
monitor
measur
felv
whole
viru
antibodi
felin
oncornavirusassoci
cell
membran
antigen
focma
assay
one
cat
show
regress
infect
transient
antigenemia
persist
provirusposit
seroconvers
proviru
found
organ
sacrific
remain
cat
focma
assay
posit
sign
infect
test
neg
overal
result
show
felv
low
dose
exposur
result
seroconvers
presum
abort
infect
therefor
commonli
use
detect
method
detect
felvinfect
anim
possibl
lead
underestim
preval
infect
felv
pathogenesi
infect
outcom
abort
infect
focma
assay
felin
leukemia
viru
felv
retroviru
great
veterinari
import
discov
year
ago
infect
domest
cat
relat
small
felid
worldwid
infect
felv
may
caus
disord
hematopoiet
cell
state
immunodefici
fatal
neoplasia
common
symptom
fever
anaemia
anorexia
weight
loss
preval
felv
infect
decreas
past
year
switzerland
felv
preval
found
healthi
ill
cat
decreas
preval
consequ
identif
segreg
infect
cat
extens
vaccin
program
howev
case
recurr
keep
occur
emphasis
import
accur
diagnosi
felv
mainli
transmit
directli
cat
cat
transmiss
occur
contact
saliva
via
lick
mutual
groom
share
food
water
dish
trough
bite
infecti
felv
also
transmit
via
faec
milk
felv
rna
also
detect
urin
infect
potenti
demonstr
far
pathogenesi
well
understood
infecti
pressur
high
infect
start
oropharynx
viru
first
replic
tonsil
local
lymph
node
viru
spread
bone
marrow
thymu
spleen
intestin
infect
lymphocyt
bone
marrow
infect
import
hallmark
felv
pathogenesi
viru
replic
extens
bone
marrow
infect
blood
precursor
cell
first
mani
organ
tissu
thereaft
includ
salivari
gland
tonsil
pharyng
urinari
bladder
gastric
intestin
colon
pancreat
endometri
epithelia
lymph
node
throughout
bodi
bone
marrow
spleen
felv
infect
present
varieti
outcom
influenc
host
viru
factor
known
host
resist
factor
includ
age
immun
system
statu
known
virolog
factor
viru
strain
subtyp
viral
infect
dose
outcom
infect
still
rather
controversi
issu
past
infect
outcom
classifi
virem
nonvirem
transient
virem
base
result
viru
isol
immunofluoresc
assay
andor
antigen
detect
virem
cat
character
continu
express
viral
antigen
felv
infect
contain
due
lack
felv
specif
immun
virem
cat
continu
shed
viru
therebi
pose
risk
infect
suscept
cat
usual
succumb
felvassoci
diseas
anaemia
immunosuppress
neoplasia
transient
virem
cat
viremia
overcom
week
postinfect
pi
howev
transient
virem
cat
remain
proviru
posit
addit
nonvirem
cat
shown
local
infect
character
viru
replic
certain
tissu
mammari
salivari
urinari
epithelium
addit
form
felv
infect
term
atyp
sequest
infect
new
sensit
molecular
assay
describ
recent
use
detect
quantif
felv
proviru
dna
viral
rna
result
sensit
measur
felv
exposur
spectrum
host
respons
categori
refin
accordingli
especi
neg
cat
outcom
reevalu
base
presenc
absenc
felv
provir
dna
blood
bone
marrow
spectrum
host
respons
categori
thu
reclassifi
abort
viru
detect
exposur
regress
proviru
posit
without
transient
antigenemia
progress
persist
posit
viru
isol
proviru
posit
felv
rna
posit
whether
cat
show
sign
infect
abort
truli
immun
resist
still
open
debat
context
interest
find
felv
infect
transmit
contact
faec
appar
viremia
infect
involv
bone
marrow
constant
neg
provir
dna
blood
would
classifi
abort
infect
howev
studi
gomeskel
et
al
felv
proviru
could
detect
sever
organ
cat
show
seroconvers
indic
infect
inde
occur
conclud
low
infecti
pressur
differ
pathogenesi
may
take
place
bone
marrow
involv
sinc
felv
transmiss
low
infect
level
appear
natur
way
infect
mani
cat
may
show
yet
uncharacter
outcom
cat
test
neg
felv
convent
diagnost
method
could
still
infect
constitut
relev
portion
cat
popul
affect
viru
preval
felv
infect
may
therefor
underestim
factor
import
consequ
felv
control
manag
eg
iberian
lynx
seem
particularli
suscept
felv
infect
correct
estim
felv
spread
potenti
great
import
thu
aim
studi
character
cours
infect
exposur
low
infecti
pressur
test
hypothesi
low
felv
dose
appli
young
cat
may
lead
seroconvers
even
infect
progress
bone
marrow
viru
may
complet
elimin
limit
viral
replic
tissu
may
lead
develop
weak
immun
respons
three
group
cat
expos
differ
low
dose
felv
blood
antigen
provir
dna
viral
rna
measur
blood
regular
interv
week
pi
poplit
mesenter
lymph
node
bone
marrow
spleen
kidney
urinari
bladder
lung
thymu
myocardium
parotid
gland
pancrea
euthanasia
immun
respons
felv
assess
detect
antibodi
elisa
felv
whole
viru
felv
recombin
envgen
product
immunofluoresc
assay
felin
oncornavirusassoci
cell
membran
antigen
focma
western
blot
analysi
separ
felv
compon
twentysix
weeksold
specif
pathogenfre
spf
male
kitten
obtain
liberti
research
inc
waverli
ny
usa
anim
kept
barrier
condit
optim
etholog
hygien
condit
one
group
cat
uninfect
control
group
three
group
cat
group
base
viral
infecti
dose
prior
begin
experi
cat
test
pcr
rtpcr
serolog
shown
neg
felv
fiv
herp
corona
calici
parvoviru
felin
hemotrop
mycoplasma
age
week
kitten
group
infect
oronas
introduc
ml
viru
suspens
nostril
ml
mouth
viru
suspens
group
contain
total
focusform
unit
ffu
one
group
ffu
group
ffu
viral
stock
origin
infect
describ
earlier
work
blood
sampl
collect
sedat
mgkg
midazolam
dormicum
roch
pharma
ag
reinach
switzerland
mgkg
ketamin
narketan
ag
belp
switzerland
prior
challeng
week
weekli
start
week
week
pi
later
biweekli
interv
week
pi
blood
sampl
obtain
jugular
venipunctur
use
ml
syring
blood
immedi
transfer
edtatub
edta
blood
submit
haematolog
analysi
edta
anticoagul
whole
blood
aliquot
dna
extract
plasma
obtain
centrifug
approxim
ml
edta
blood
g
min
blood
plasma
sampl
immedi
frozen
process
determin
felv
provir
load
total
nucleic
acid
extract
blood
volum
contain
white
blood
cell
use
magna
pure
lc
total
nucleid
acid
isol
kit
roch
diagnost
ag
rotkreuz
switzerland
extract
total
nucleic
acid
analyz
realtim
taqman
pcr
describ
use
taqman
fast
univers
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
abi
sequenc
detect
system
appli
biosystem
follow
cycl
condit
initi
denatur
follow
cycl
run
dehydrogenas
gapdh
pseudogen
one
copi
present
genom
dna
felin
cell
also
quantifi
describ
use
taqman
fast
univers
pcr
master
mix
pcr
run
condit
felv
proviru
felv
provir
dna
amount
normal
felin
gapdh
divid
felv
copi
number
fgapdh
copi
number
calcul
felv
copi
per
cell
viral
rna
plasma
sampl
extract
plasma
either
pool
singl
sampl
use
magna
pure
lc
total
nucleic
isol
kit
quantifi
realtim
taqman
revers
transcriptas
rt
pcr
describ
use
abi
sequenc
detect
system
presenc
plasma
felv
antigen
determin
use
sandwich
elisa
previous
describ
felin
lymphoblastoid
cell
line
perman
express
felv
consid
sampl
reach
posit
control
signal
consid
posit
plasma
sampl
also
analys
presenc
antibodi
felv
whole
viru
felv
nonglycosyl
form
surfac
unit
envelop
glycoprotein
focma
antifelv
antifelv
whole
viru
antibodi
measur
elisa
describ
use
ng
ng
gradient
purifi
felv
respect
plasma
use
dilut
antibodi
level
assess
comparison
predefin
control
antisera
antibodi
focma
measur
week
week
pi
indirect
cell
membran
immunofluoresc
describ
cell
cultur
medium
test
absenc
fcv
fhv
fpv
fcov
fiv
hemotrop
mycoplasma
presenc
felv
rtpcrpcr
describ
cultur
consist
free
unwant
contamin
cat
sera
titrat
dilut
sampl
show
minim
titr
consid
focma
posit
addit
sampl
week
week
pi
examin
presenc
antibodi
felv
e
western
blot
analysi
describ
cat
group
group
euthan
week
tissu
sampl
poplit
mesenter
lymph
node
bone
marrow
spleen
kidney
urinari
bladder
lung
thymu
myocardium
parotid
gland
pancrea
collect
within
min
postmortem
sampl
snapfrozen
liquid
nitrogen
ten
mg
tissu
use
extract
dna
use
magna
pure
lc
dna
isol
kit
ii
tissu
kit
roch
diagnost
felv
proviru
quantifi
realtim
pcr
describ
guarante
compar
sensit
sampl
yield
less
fgapdh
copi
per
reaction
reextract
suitabl
concentr
reach
addit
sampl
collect
steril
condit
mesenter
lymph
node
urinari
bladder
lung
thymu
myocardium
viru
isol
tissu
sampl
cocultur
fea
cell
supernat
cocultur
collect
day
postinocul
test
antigen
elisa
describ
bone
marrow
sampl
cultur
medium
supernat
collect
day
use
total
nucleic
acid
isol
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
sampl
test
presenc
felv
rna
addit
supernat
test
elisa
statist
analys
carri
use
r
softwar
version
r
foundat
statist
comput
vienna
austria
longitudin
effect
time
antibodi
titr
differ
group
compar
multivari
analysi
varianc
manova
p
valu
consid
statist
signific
one
except
cat
becom
proviru
posit
time
point
test
one
cat
found
posit
belong
group
challeng
highest
three
dose
felv
ffu
provir
dna
detect
week
pi
peak
week
copiescel
fig
similarli
viral
rna
consist
detect
sampl
provirusposit
cat
week
addit
week
highest
viral
rna
load
measur
week
pi
ctvalu
fig
viral
rna
detect
pool
plasma
sampl
sampl
pool
provirusneg
cat
week
pi
addit
sampl
week
test
individu
viral
rna
peak
usual
occur
time
period
result
neg
antigen
detect
plasma
one
cat
test
cat
becam
transient
posit
week
pi
week
pi
fig
detect
time
point
cat
measur
antibodi
felv
whole
viru
elisa
seroconvers
observ
one
cat
elisa
cat
posit
respons
throughout
week
peak
posit
control
week
throughout
week
peak
posit
control
week
felv
whole
viru
elisa
data
shown
analysi
remain
anim
show
statist
relev
differ
group
well
whole
viru
elisa
p
manova
respect
fig
prior
challeng
sampl
neg
presenc
antibodi
direct
focma
week
pi
antibodi
focma
detect
cat
group
cat
group
cat
pcrposit
cat
reach
highest
titr
cat
develop
antibodi
titr
rang
neg
control
group
group
anim
detect
titr
tab
western
blot
analysi
sera
cat
group
show
weak
reactiv
upper
band
e
protein
serum
dilut
well
howev
cat
show
reactiv
upper
band
e
alreadi
week
pi
fig
pcrposit
cat
presenc
antibodi
felv
confirm
dilut
cat
group
either
complet
neg
western
blot
pattern
show
crossreact
band
alreadi
present
week
cat
fig
week
postchalleng
cat
group
euthan
differ
tissu
sampl
collect
analys
presenc
felv
dna
sequenc
poplit
mesenter
lymph
node
bone
marrow
spleen
kidney
urinari
bladder
lung
thymu
myocardium
parotid
gland
pancrea
test
felv
dna
sequenc
found
organ
cat
posit
felv
proviru
blood
copi
number
averag
low
rang
copiesreact
copiescel
data
shown
poplit
lymph
node
show
highest
felv
provir
load
copiescel
felv
dna
sequenc
detect
tissu
sampl
cat
viru
isol
urinari
bladder
myocardium
lung
mesenter
lymph
node
thymu
bone
marrow
neg
cat
aim
studi
investig
degre
cat
becom
infect
low
dose
oral
felv
infect
without
detect
involv
bone
marrow
even
though
felv
preval
reportedli
decreas
past
year
felv
still
among
import
infecti
diseas
cat
henc
deep
knowledg
aspect
felv
pathogenesi
biolog
essenti
recent
novel
cours
infect
postul
week
week
week
week
week
week
week
deviat
classic
cours
involv
phase
bone
marrow
infect
altern
cours
cat
expos
low
load
viru
via
faecal
rout
seroconvert
without
involv
bone
marrow
without
show
sign
infect
studi
demonstr
singl
oronas
exposur
felv
low
ffu
suffici
elicit
antibodi
respons
lead
seroconvers
least
lower
confid
interv
distribut
cat
demonstr
postul
altern
cours
infect
may
occur
consider
portion
anim
propos
design
outcom
infect
abort
infect
seroconvers
hallmark
infect
observ
cat
receiv
smallest
three
dose
ffu
individu
local
innat
immun
might
enough
contain
viral
replic
lead
abort
infect
without
detect
adapt
immun
respons
howev
field
condit
multipl
exposur
rang
ffu
lower
may
occur
give
rise
seroconvers
even
proviru
posit
consid
assay
provir
dna
abl
detect
one
copi
per
reaction
believ
consist
pcrneg
blood
cat
seroconvert
strong
indic
absenc
bone
marrow
infect
confirm
altern
cours
infect
may
inde
exist
bone
marrow
involv
felv
proviru
may
still
integr
genom
cell
tissu
case
level
beyond
detect
studi
present
felv
dna
sequenc
detect
organ
test
howev
presenc
felv
proviru
tissu
one
analys
exclud
investig
local
infect
felv
replic
confin
certain
tissu
presenc
plasma
viral
rna
load
regard
sensit
paramet
infect
rna
load
reflect
ongo
viral
replic
somewher
cat
bodi
even
sequest
place
howev
detect
rna
gener
less
frequent
provir
dna
seroconvers
observ
use
cell
membran
immunofluoresc
test
assay
origin
design
focma
test
thought
detect
antibodi
nonvirion
tumourassoci
antigen
later
becam
clear
focma
phenomenon
explain
tumour
specif
antigen
viral
protein
includ
felv
e
gagpolyprotein
felv
subtyp
c
present
cell
membran
cell
membran
immunofluoresc
test
seem
sensit
method
detect
seroconvers
compar
elisa
western
blot
may
due
part
less
stringent
test
condit
allow
antibodi
lower
affin
bind
epitop
part
fact
focma
assay
bind
target
present
nativ
conform
thu
allow
better
bind
conformationspecif
antibodi
induct
cytotox
tcell
virusneutr
antibodi
oral
low
dose
infect
cytokin
express
might
induc
experiment
infect
measur
instead
antibodi
respons
use
marker
infect
unclear
degre
altern
pathway
may
relev
spread
felv
infect
specul
case
cat
overcom
infect
good
case
infect
cat
undergo
immunosuppress
due
eg
concomit
fiv
infect
fullblown
felv
infect
bone
marrow
involv
viral
shed
may
develop
import
determin
extent
may
occur
conclus
present
studi
provid
addit
evid
exist
altern
felv
infect
cours
lead
develop
antibodi
without
involv
bone
marrow
result
may
import
surveil
felv
statu
catteri
cat
popul
like
catteri
consid
free
felv
long
cat
felvreact
antibodi
present
potenti
overt
infect
neglect
